CVDs are one of the major causes of death. About 19.8 million people died from CVDs in 2022. Nearly 85% of these deaths were caused by heart attack and stroke. In the US, about 805,000 people have a heart attack at least once in their life.
CVDs affect people of all ages and genders. Common CVDs are:
- Coronary Artery Disease (CAD)
- Cerebrovascular Disease
- Peripheral Artery Disease (PAD)
- Heart Failure
- Hypertension (High Blood Pressure)
- Congenital Heart Disease
- Rheumatic Heart Disease
- Arrhythmias
Most CVDs can be prevented, but early diagnosis is very important. This is where polyclonal antibodies come into play.
What are Polyclonal Antibodies?
Polyclonal antibodies (pAbs) are a heterogeneous mixture of immunoglobulins produced by different B-cell clones. They are designed to identify and bind to multiple epitopes of the same antigen.
They are known for:
- High sensitivity
- Robust detection
- High tolerance to antigen variability
- Cost-effective and fast production
pAbs can detect various CVD biomarkers, such as CRP, MMPs, cTnl, cTnT, BNP, and NT-proBNP.
What are the Common Applications of a Polyclonal Antibody?
ELISA
ELISA means Enzyme-Linked Immunosorbent Assay. It is a plate-based test. It helps detect CVD biomarkers in a sample, even when their levels are very low. This technique relies on antigen-antibody interactions.
pAbs produce a strong and amplified signal proportional to the amount of biomarkers present in the sample.
IHC
IHC (Immunohistochemistry) is a lab method used to find specific proteins in tissue samples, such as heart tissue or blood vessels.
In IHC, pAbs stain the CVD biomarkers. A fluorescent signal appears, which can be seen under a microscope. Because pAbs bind to many epitopes, they give a brighter and clearer signal.
This makes them ideal for proteins that are present in very small amounts.
- IHC also shows where the biomarker is located in the tissue.
- It helps researchers study tissue damage, inflammation, cell death, plaque formation, and other changes seen in cardiovascular diseases and many other conditions.
WB
Western Blotting (WB) is another widely used application of polyclonal antibodies. It is a technique used to separate, detect, and measure proteins from a blood or tissue sample.
In this method, proteins are first separated on a gel and then transferred onto a membrane. Polyclonal antibodies are added to detect the CVD biomarkers present on that membrane.
pAbs are used in WB because they bind to multiple parts of the same protein. As a result, they create strong and clear bands on the membrane. They are ideal for the detection of different forms of the biomarker, even if it has been slightly changed or broken down.
Flow Cytometry
Flow cytometry is used to analyze and count different types of cells in the blood. This technique helps researchers understand how cell populations change in cardiovascular diseases.
pAbs can bind to cell-surface markers and produce a bright and clear signal. They also help identify immune cells involved in inflammation, plaque formation, or vascular injury. So, they are ideal to study monocytes, T-cells, endothelial progenitor cells, and other circulating cells that influence heart health.
Rapid Test Kits
Rapid test kits are designed for quick diagnosis, especially during emergency situations like suspected heart attacks. These tests commonly use polyclonal antibodies due to their high sensitivity, quick, and accurate results. pAbs help detect cardiac troponins quickly and help doctors make quick decisions during acute cardiac events.
The Bottom Line
Now that you know how pAbs are helpful in CVDs and their common applications, what are you waiting for? Find a reliable supplier, like AAA Biotech (also known as aaaBio), to buy high-quality polyclonal antibodies that can support your lab technique and give you accurate and reproducible results!
